MEDIA STATEMENT
For Immediate Release
March 14, 2012
Status: Minimal Impact – Continue to Monitor
Our first priority continues to be our patients and their care. We are working to ensure that we have the medication needed to meet the clinical needs of patients and continue safe and effective treatment plans.
Our management teams continue to source alternative medication supplies, assess the impact this interruption will have on our supplies, gather information from Sandoz directly and make changes to clinical operations as required. In addition, we are collaborating with Hospital Buying Groups, South West LHIN, Ontario Hospital Association, Ministry of Health and Long-term Care and other key stakeholders to address any potential drug shortages.
Because of some shipment allocations from Sandoz and sourcing of alternative medications, LHSC and St. Joseph’s continue to have a two to eight week supply of these drugs and so therefore our current situation is manageable. However, regularly monitoring will ensure we are aware of any low volumes of supplies so that alternative solutions can be put into place prior to becoming crucial.
Neil Johnson Chris Judd
VP, Clinical Support and Business Development Director, Pharmacy
London Health Sciences Centre St. Joseph’s Health Care London
- 30 -
Contact for more information:
Michele Martin Kelsi Break
London Health Sciences Centre St. Joseph’s Health Care London
(519) 685-8500, ext. 77062 (519) 646-6100, ext. 64792
After-hours assistance:
Call LHSC Switchboard at 519-685-8500 or St. Joseph’s Switchboard at 519-646-6000 and ask to page the communicator on-call.
